Signatope GmbH

Signatope GmbH

Biotechnology-Research

55, Hauptsitz
Industry Category
Biotechnology-Research
Company Description

Signatope GmbH is a pioneering biotechnology research company dedicated to advancing the field through innovative protein biomarker assays. Utilizing cutting-edge immunoaffinity-based mass spectrometry, Signatope GmbH develops next-generation assays applicable to both human samples and pharmacologically relevant model species.

Based in Markwiesenstraße 55, Hauptsitz, DE, Signatope GmbH is committed to providing solutions that drive progress in research and development. The company's focus on precision and comprehensive coverage ensures reliable and impactful results for its partners.

Signatope GmbH is poised for continued growth and success in the biotechnology sector. We invite the management of Signatope GmbH to create a customized and exclusive company showcase and product listing on our platform, enhancing their visibility and commercial opportunities.

Key Personnel / Employees
Dr. Lena-Sophie Schütter Hannes Planatscher Helen Hammer Oliver Pötz

Similar Companies

Other organizations in the same industry

BIOTECanada
Biotechnology-Research

Solving for today. Building for tomorrow.

Ottawa, Ontario
Canada
Alkira Bio
Biotechnology-Research

Enabling the discovery of next-generation therapeutic antibodies targeting complex membrane proteins

Melbourne, Victoria
Australia
Certa Therapeutics
Biotechnology-Research

Developing innovative precision therapies for the treatment of inflammatory and fibrotic diseases

exteRNA
Biotechnology-Research

exteRNA is focused on developing novel small-molecule therapeutics that target RNA processing pathwa...

Alternative Company Names

This company is also known as

Signatope GmbH सिग्नाटोप जीएमबीएच سيجناتوب جي إم بي إتش Сигнатопе ГмбХ